{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:47:41Z","timestamp":1775627261212,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe and assess the appropriateness of prescribing for older adults with atrial fibrillation (AF) presenting to a multidisciplinary outpatient clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective observational study of medical records of patients who attended a specialist AF outpatient clinic over a 1-year period. Prescribing was assessed using the STOPP\/START Criteria (Version 2). Direct oral anticoagulant prescribing was assessed separately. Risk factors for Potentially Inappropriate Medications (PIM) and Potential Prescribing Omissions (PPO) were assessed through multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>One hundred and sixty-eight patients (median age: 74\u00a0years; range: 65\u201394\u00a0years; 59.4% male) were included. Patients had a median of six comorbidities (IQR 4\u20139) and were prescribed a median of six medications (IQR 4\u20139). Minor polypharmacy (5\u20139 medications) was found in 53.0% (n\u2009=\u200989), and major polypharmacy (&amp;gt;9 medications) was found in 21.4% (n\u2009=\u200936). Potentially inappropriate prescribing was present in 75.6% (n\u2009=\u2009127). The majority (60.1%, n\u2009=\u2009101) had at least one potentially inappropriate medication, and 46.4% (n\u2009=\u200978) had a potential prescribing omission. Anticoagulants were inappropriately dosed in 11.6% (n\u2009=\u200913) of patients. There were positive associations between number of medications prescribed and PIM (P\u2009=\u2009&amp;lt; .001), and number of comorbidities and PPO (P\u2009=\u2009&amp;lt; .001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Polypharmacy and potentially inappropriate prescribing were prevalent in this population of older adults with AF. Interventions are needed to optimize prescribing in this cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riag043","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:43:03Z","timestamp":1773146583000},"source":"Crossref","is-referenced-by-count":0,"title":["Potentially inappropriate prescribing and polypharmacy in older adults with atrial fibrillation: a retrospective observational study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7005-8757","authenticated-orcid":false,"given":"Iarlaith","family":"Doherty","sequence":"first","affiliation":[{"name":"Pharmacy Department, Tallaght University Hospital , Dublin, D24NR0A ,","place":["Ireland"]},{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin , Dublin, D02VF25 ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4254-0614","authenticated-orcid":false,"given":"Anna","family":"Seoighe","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Tallaght University Hospital , Dublin, D24NR0A ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal A","family":"Cadogan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin , Dublin, D02VF25 ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9398-4339","authenticated-orcid":false,"given":"Christine","family":"McAuliffe","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Tallaght University Hospital , Dublin, D24NR0A ,","place":["Ireland"]},{"name":"School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences , Dublin, D02VN51 ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"2026040801000408400_ref1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"2026040801000408400_ref2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/qjmed\/hcw011","article-title":"Opportunistic screening for atrial fibrillation in a rural area","volume":"109","author":"Smyth","year":"2016","journal-title":"QJM."},{"key":"2026040801000408400_ref3","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/strokeaha.111.645721","article-title":"Incidence, event rates, and early outcome of stroke in Dublin, Ireland: the North Dublin population stroke study","volume":"43","author":"Kelly","year":"2012","journal-title":"Stroke."},{"key":"2026040801000408400_ref4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"2026040801000408400_ref5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00392-015-0936-y","article-title":"Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026040801000408400_ref6","doi-asserted-by":"publisher","first-page":"e001257","DOI":"10.1136\/openhrt-2020-001257","article-title":"Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis","volume":"7","author":"Gallagher","year":"2020","journal-title":"Open Heart"},{"key":"2026040801000408400_ref7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine safety: when many is not too many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf"},{"key":"2026040801000408400_ref8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"2026040801000408400_ref9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2017.07.108","article-title":"Prevalence and predictors of inappropriate anticoagulation in patients with a CHA(2)DS(2)-VASc score of 0 and atrial fibrillation","volume":"248","author":"Saberian","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026040801000408400_ref10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40266-017-0477-3","article-title":"Underuse of Oral anticoagulants and inappropriate prescription of antiplatelet therapy in older inpatients with atrial fibrillation","volume":"34","author":"Averlant","year":"2017","journal-title":"Drugs Aging"},{"key":"2026040801000408400_ref11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/cpdd.385","article-title":"Prevalence of potential drug-drug interactions with direct oral anticoagulants in elderly inpatients","volume":"6","author":"Polasek","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2026040801000408400_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy140.28","article-title":"Experiences of direct oral anticoagulants [DOAC] prescribing on an acute geriatric service and rehabilitation ward","author":"Jennings","year":"2018","journal-title":"Age Ageing"},{"key":"2026040801000408400_ref13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11239-021-02528-x","article-title":"Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation","volume":"53","author":"Li","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"2026040801000408400_ref14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct Oral anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026040801000408400_ref15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.18549\/PharmPract.2016.02.706","article-title":"Old age, high risk medication, polypharmacy: a 'trilogy' of risks in older patients with atrial fibrillation","volume":"14","author":"Wang","year":"2016","journal-title":"Pharm Pract (Granada)"},{"key":"2026040801000408400_ref16","doi-asserted-by":"publisher","first-page":"1476464","DOI":"10.3389\/fphar.2024.1476464","article-title":"Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study","volume":"15","author":"Amrouch","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026040801000408400_ref17","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1111\/bcp.14870","article-title":"Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: a systematic review and meta-analysis","volume":"87","author":"Mekonnen","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2026040801000408400_ref18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijmedinf.2018.12.010","article-title":"Conversion of STOPP\/START version 2 into coded algorithms for software implementation: a multidisciplinary consensus procedure","volume":"125","author":"Huibers","year":"2019","journal-title":"Int J Med Inform"},{"key":"2026040801000408400_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","author":"O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"2026040801000408400_ref20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol Opt"},{"key":"2026040801000408400_ref21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40266-023-01078-6","article-title":"Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: a systematic review and meta-analysis","volume":"41","author":"Amrouch","year":"2024","journal-title":"Drugs Aging"},{"key":"2026040801000408400_ref22","article-title":"Polypharmacy in adults over 50 in Ireland: opportunities for cost saving and improved healthcare. The Irish longitudinal study on aging,","author":"Richardson","year":"2012"},{"key":"2026040801000408400_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.0570","article-title":"Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic","author":"Suleiman","year":"2021","journal-title":"Eur Heart J"},{"key":"2026040801000408400_ref24","doi-asserted-by":"publisher","first-page":"988799","DOI":"10.3389\/fcvm.2022.988799","article-title":"Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: a report from the China atrial fibrillation registry study","volume":"9","author":"Guo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026040801000408400_ref25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12877-021-02715-8","article-title":"Factors associated to potentially inappropriate prescribing in older patients according to STOPP\/START criteria: MoPIM multicentre cohort study","volume":"22","author":"Bar\u00e9","year":"2022","journal-title":"BMC Geriatr"},{"key":"2026040801000408400_ref26","first-page":"436","article-title":"Falls and atrial fibrillation in elderly patients","volume":"29","author":"Hung","year":"2013","journal-title":"Acta Cardiol Sin"},{"key":"2026040801000408400_ref27","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: II","volume":"19","author":"Seppala","year":"2018","journal-title":"Psychotropics J Am Med Dir Assoc"},{"key":"2026040801000408400_ref28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/hrp.0000000000000190","article-title":"Prescription benzodiazepine use among older adults: a critical review","volume":"26","author":"Gerlach","year":"2018","journal-title":"Harv Rev Psychiatry"},{"key":"2026040801000408400_ref29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12877-022-02757-6","article-title":"Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing","volume":"22","author":"Scharner","year":"2022","journal-title":"BMC Geriatr"},{"key":"2026040801000408400_ref30","doi-asserted-by":"publisher","first-page":"e000108","DOI":"10.1161\/HCQ.0000000000000108","article-title":"Preventing and managing falls in adults with cardiovascular disease: a scientific statement from the American Heart Association","volume":"15","author":"Denfeld","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026040801000408400_ref31","doi-asserted-by":"publisher","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026040801000408400_ref32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00228-015-1815-1","article-title":"Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people","volume":"71","author":"Moriarty","year":"2015","journal-title":"Eur J Clin Pharmacol"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag043\/67867327\/riag043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag043\/67867327\/riag043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:00:07Z","timestamp":1775624407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article\/doi\/10.1093\/ijpp\/riag043\/8607019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riag043","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"article-number":"riag043"}}